Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2026-06-29 16:33:30 ET · period of report 2026-06-29 · accession 0001628280-26-046015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-29 16:33 | 2026-06-29 | TLSI | Marshall Richard Henry | Chief Medical Off | A - Grant | $0.00 | +60.0K | 90.0K | +200% | $0 |
| D | 2026-06-29 16:33 | 2026-06-29 | TLSI | Marshall Richard Henry | Chief Medical Off | A - Grant | $0.00 | +120.0K | 253.0K | +90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | A | A | 60,000 | $0.00 | 90,000 | D | — | — | (F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2026-06-29 | A | A | 120,000 | $0.00 | 253,000 | D | $4.74 · — to 2036-06-29 | 120,000 Common Stock | (F2) One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. |